Jason Fontenot

We are Stylus Medicine - an in vivo genetic medicines company with a bold vision to reimagine and expand the reach of transformative genetic medicines, starting with in vivo CAR-T therapies. Learn more: businesswire.com/news/home/2025…

Exclusive: Patrick Hsu’s startup Stylus Medicine launches, looks beyond CRISPR for gene insertion tech - endpts.com/exclusive-patr…

Zinc Finger Repressors mediate widespread PRNP lowering in the nonhuman primate brain and profoundly extend survival in prion disease mice | bioRxiv. Impressive work, exciting prospect for human study. biorxiv.org/content/10.110…

@f_fauser @SangamoTx Truly impressive work, Frieder! Congrats.

We are thrilled to reveal @SangamoTx‘s Modular Integrase (MINT) platform at #ASGCT2024. Our MINT platform is a protein-guided genome editing method designed to facilitate targeted integration (TI) of synthetic DNA into chromosomal sites. PDF: sangamo.com/science/public… [1/10]

@SunLab_Official @SchietingerLab @MSKCancerCenter @UW_Immunology Congrats, Andrea. Great photo.

Huge congrats to my colleague Andrea Schietinger @SchietingerLab on her well deserved promotion to FULL member at @MSKCancerCenter! So special to have her former mentor Phil Greenberg be in town for the celebration. We had to a snap a @UW_Immunology reunion photo!

@jaffeab @chromamedicine @morganlmaeder @CSHL As a start, I would humbly propose an effort eliminate unnecessarily restrictive terms from genome engineering conference titles. Is the international conference on animal flight titled - Chiroptera2023 …and nice work @chromamedicine! Welcome to the future.

Fantastic talk by @chromamedicine colleague @morganlmaeder yesterday @CSHL Genome Engineering! Maybe it's time to rename the meeting to (Epi)genome Engineering? #CSHLCRISPR23

@UrnovFyodor Indeed. Heroic.

The courage of this woman scientist standing up for herself and for what's right reminds me of what Jennifer Doudna said when asked, by a female student, for career advice: "Walk into every room like you OWN THE PLACE." BRAVA! to this person and all #WomenInSTEM for doing so.

Interested in our innovative approach to use iPSCs as a renewable source of allogeneic cells to enable Treg cell therapy manufacturing at scale? Helen Fong, Sangamo's Sr. Scientist joins the @FOCISimmunology Meeting for an oral presentation. Learn more: bit.ly/3J2s9CS

It’s the last day at #ASGCT23 and we’re excited to wrap up a total of 14 presentations featuring progress across our pipeline. For the latest on all of our presentations, visit our website: bit.ly/43mWO5R

Today we’re showcasing our Viral Delivery Capabilities for Neurology. To discover how our cutting-edge delivery science is progressing, visit the website: bit.ly/43mWO5R #ASGCT23

Join us at #ASGCT23, where we’ll showcase progress in our pre-clinical programs, including innovations in epigenetic regulation for neurological disorders & our latest advancements in AAV capsid engineering for delivery. See details: bit.ly/3HvNDHD #ZincFinger

@jaybradner hear, hear!

Three of thirteen new medicines approved by the FDA have “J” names. Let’s all work together to keep this good thing we have going. fda.gov/drugs/new-drug…

@KingOfPathogens @mike_feigin Share?

@mike_feigin You do what with tuna?

Using #Tregs no less!

Zietler presenting amazing data on Prnp knockdown and prion survival benefits by AAV delivered zinc finger by mouse tail vein injection. Wow this is so exciting. Sangamo therapeutics and the irrepressible Minikel Vallabh team 👏 👏 👏 my surprise good news of #prion2022

Kudos to Bryan Zeitler and the team for the exciting work #prion2022 @SangamoTx

@LabListon @JExpMed @CarlyEWhyte @singhkailash04 @jldvib Beautiful work, @LabListon.

Our latest work is out in @JExpMed! Work by @CarlyEWhyte, @singhkailash04, @jldvib and co on the context-dependent effects of the #IL2 network. One of the oldest and most important #cytokines and we are still learning news things about it! 1/17 rupress.org/jem/article/21…

Sangamo AAV engineering is firing on all cylinders

Today at 4pm ET, join our oral presentation at #ASGCT22 to learn how AAV capsids are designed to provide broad CNS access while minimizing exposure to pre-existing anti-AAV antibodies. More: bit.ly/3xKCMW0 #ASGCT #GenomicMedicine #GeneTherapy #CellTherapy

Love when our @SangamoTX team has an excuse to get together for food, great science talk and lots of laughs. A fun evening with brilliant colleagues! Now enjoying Day 3 of #ASGCT22.